Oxendolone

Oxendolone is a steroid that was developed for medical use. It is a synthetic and orally active anabolic–androgenic steroid (AAS) and a 17α-alkylated derivative of testosterone. Oxendolone was never marketed and is not currently available as a prescription medication.

Etymology

The term "Oxendolone" is derived from the chemical structure of the compound. The "Oxen" part of the name refers to the presence of an oxygen atom in the molecule, while the "dolone" part is a common suffix used in the names of steroids.

Pharmacology

As an AAS, Oxendolone is an agonist of the androgen receptor, the biological target of androgens like testosterone. It has strong anabolic effects and weak androgenic effects, which give it a mild side effect profile and make it especially suitable for use in women.

Chemistry

Oxendolone, also known as 17α-methyl-5α-androst-1-en-3-one, is a synthetic estrane steroid and a derivative of testosterone. It is more specifically a derivative of methyltestosterone, which is testosterone with a methyl group at the C17α position.

History

Oxendolone was first described in the literature in 1963. It was developed for medical use but was never marketed.

See also

• List of androgens/anabolic steroids

Oxendolone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia